Lonza to Buy Genentech Plant for $150 Million to Boost Avastin Production
Published by FDA - Topix.net November 8th, 2006 in UncategorizedLonza Group AG agreed to pay $150 million for a Genentech Inc. factory in Spain to help become the world’s largest maker of drug ingredients and expand its ability to make the cancer treatment Avastin and other …
Comment